Equity Overview
Price & Market Data
Price: $143.2
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $33,987,043,328
Volume: 0
Performance Metrics
1 Week: 12.72%
1 Month: 19.30%
3 Months: 19.30%
6 Months: 47.59%
1 Year: 84.19%
YTD: 19.30%
Details
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.